Tirzepatide for Obesity and Meth Use Disorder

NCT06745128 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Methamphetamine Use Disorder

Interventions

DRUG: Tirzepatide

Sponsor

University of Texas Southwestern Medical Center